Prof. Sarah Lebeer's research team consists of a group of scientists who are fascinated by bacteria and their positive influence on our health. This multidisciplinary team consists of microbiologists, bioinformaticians and bioengineers and often works together with doctors, such as dermatologists, gynaecologists and general practitioners. They study the microbiome of humans, animals and plants and focus on lactobacilli isolated from different habitats to unravel their health-promoting properties. By applying molecular, immunological and computational techniques, they aim to find new biotechnological solutions to protect humans, animals and crops from disease.
This research is driven by great concern about the frequent use of antibiotics and the lack of alternatives. The World Health Organisation predicts that more people are likely to die from antibiotic-resistant microbes than from cancer by 2050 if we do not change the way we use antibiotics.